Vaxcyte, Inc.
Vaxcyte, Inc.（PCVX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · PCVX · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
12
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Vaxcyte, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
PCVX 季度内部人买卖趋势
PCVX 内幕交易卖出 · PCVX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · PCVX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
PCVX 高管卖出股份 · PCVX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 1, 2026 | Wassil Jim CHIEF OPERATING OFFICER | Sale | 2,250 | $128K | Form 4 |
| Apr 7, 2026 | Cowan Elvia SVP, Finance & CAO | Option | 3,000 | $78K | Form 4 |
| Apr 7, 2026 | Cowan Elvia SVP, Finance & CAO | Sale | 3,000 | $180K | Form 4 |
| Apr 1, 2026 | Wassil Jim CHIEF OPERATING OFFICER | Sale | 1,412 | $82K | Form 4 |
| Apr 1, 2026 | Wassil Jim CHIEF OPERATING OFFICER | Sale | 838 | $49K | Form 4 |
| Mar 17, 2026 | Cowan Elvia SVP, Finance & CAO | Sale | 1,487 | $82K | Form 4 |
| Mar 17, 2026 | Cowan Elvia SVP, Finance & CAO | Sale | 405 | $23K | Form 4 |
| Mar 9, 2026 | Dhaliwal Harpreet S. Chief Technical Ops Officer | Other | 604 | $36K | Form 4 |
| Mar 9, 2026 | PICKERING GRANT CHIEF EXECUTIVE OFFICER · Director | Other | 3,685 | $219K | Form 4 |
| Mar 9, 2026 | GUGGENHIME ANDREW PRESIDENT AND CFO | Other | 1,021 | $61K | Form 4 |
| Mar 11, 2026 | Cowan Elvia SVP, Finance & CAO | Option | 2,500 | $65K | Form 4 |
| Mar 11, 2026 | Cowan Elvia SVP, Finance & CAO | Sale | 2,500 | $146K | Form 4 |
| Mar 9, 2026 | Cowan Elvia SVP, Finance & CAO | Other | 495 | $29K | Form 4 |
| Mar 9, 2026 | Wassil Jim CHIEF OPERATING OFFICER | Other | 975 | $58K | Form 4 |
| Mar 10, 2026 | Wassil Jim CHIEF OPERATING OFFICER | Sale | 2,427 | $142K | Form 4 |
| Mar 10, 2026 | Wassil Jim CHIEF OPERATING OFFICER | Sale | 4,968 | $294K | Form 4 |
| Feb 26, 2026 | Cowan Elvia SVP, Finance & CAO | Option | 7,716 | $200K | Form 4 |
| Feb 28, 2026 | Cowan Elvia SVP, Finance & CAO | Other | 243 | $15K | Form 4 |
| Mar 2, 2026 | Cowan Elvia SVP, Finance & CAO | Other | 326 | $20K | Form 4 |
| Feb 26, 2026 | Cowan Elvia SVP, Finance & CAO | Award | 10,681 | — | Form 4 |
| Feb 26, 2026 | GUGGENHIME ANDREW PRESIDENT AND CFO | Award | 44,864 | — | Form 4 |
| Feb 28, 2026 | GUGGENHIME ANDREW PRESIDENT AND CFO | Other | 898 | $56K | Form 4 |
| Mar 2, 2026 | GUGGENHIME ANDREW PRESIDENT AND CFO | Other | 1,009 | $63K | Form 4 |
| Feb 26, 2026 | PICKERING GRANT CHIEF EXECUTIVE OFFICER · Director | Award | 105,110 | — | Form 4 |
| Feb 28, 2026 | PICKERING GRANT CHIEF EXECUTIVE OFFICER · Director | Other | 2,863 | $177K | Form 4 |
Dhaliwal Harpreet S.
Chief Technical Ops Officer
日期
Mar 9
股数
604
均价
$59.32
总金额
$36K
PICKERING GRANT
CHIEF EXECUTIVE OFFICER · Director
日期
Mar 9
股数
3,685
均价
$59.32
总金额
$219K
PICKERING GRANT
CHIEF EXECUTIVE OFFICER · Director
日期
Feb 26
股数
105,110
均价
—
总金额
—
PICKERING GRANT
CHIEF EXECUTIVE OFFICER · Director
日期
Feb 28
股数
2,863
均价
$61.98
总金额
$177K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 PCVX 内幕交易
PCVX 内幕交易
Vaxcyte, Inc.（PCVX）内幕交易数据来源于公司内部人（包括Cowan Elvia (SVP, Finance & CAO), Wassil Jim (CHIEF OPERATING OFFICER), GUGGENHIME ANDREW (PRESIDENT AND CFO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。PCVX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Vaxcyte, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
PCVX 内幕交易 · 5个问题Vaxcyte, Inc.（PCVX）的内部人包括高管和董事，如Cowan Elvia (SVP, Finance & CAO), Wassil Jim (CHIEF OPERATING OFFICER), GUGGENHIME ANDREW (PRESIDENT AND CFO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026